KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) EBT Margin (2020 - 2025)

Organon has reported EBT Margin over the past 6 years, most recently at 9.82% for Q4 2025.

  • Quarterly results put EBT Margin at 9.82% for Q4 2025, down 1792.0% from a year ago — trailing twelve months through Dec 2025 was 6.84% (down 577.0% YoY), and the annual figure for FY2025 was 6.84%, down 577.0%.
  • EBT Margin for Q4 2025 was 9.82% at Organon, down from 15.17% in the prior quarter.
  • Over the last five years, EBT Margin for OGN hit a ceiling of 31.01% in Q1 2021 and a floor of 98.45% in Q4 2022.
  • Median EBT Margin over the past 5 years was 14.67% (2021), compared with a mean of 9.16%.
  • Biggest five-year swings in EBT Margin: tumbled -11317bps in 2022 and later skyrocketed 10496bps in 2023.
  • Organon's EBT Margin stood at 14.72% in 2021, then plummeted by -769bps to 98.45% in 2022, then soared by 107bps to 6.51% in 2023, then increased by 25bps to 8.1% in 2024, then tumbled by -221bps to 9.82% in 2025.
  • The last three reported values for EBT Margin were 9.82% (Q4 2025), 15.17% (Q3 2025), and 14.37% (Q2 2025) per Business Quant data.